| An earlier diagnosis is a key strategy for improving the outcomes of patients with cancer. However, achieving this goal can be challenging, particularly for the growing number of people with one or more chronic conditions (comorbidity/multimorbidity) at the time of diagnosis. Pre-existing chronic diseases might affect patient participation in cancer screening, help-seeking for new and/or changing symptoms and clinicians' decision-making on the use of diagnostic investigations. Evidence suggests, for example, that pre-existing pulmonary , cardiovascular, neurological and psychiatric conditions are all associated with a more advanced stage of cancer at diagnosis. By contrast, hypertension and certain gastrointestinal and musculoskeletal conditions might be associated with a more timely diagnosis. In this Review , we propose a comprehensive framework that encompasses the effects of disease-specific, patient-related and health-care-related factors on the diagnosis of cancer in individuals with pre-existing chronic illnesses. Several previously postulated aetiological mechanisms (including alternative explanations, competing demands and surveillance effects) are integrated with newly identified mechanisms, such as false reassurances, or patient concerns about appearing to be a hypochondriac. By considering specific effects of chronic diseases on diagnostic processes and outcomes, tailored early diagnosis initiatives can be developed to improve the outcomes of the large proportion of patients with cancer who have pre-existing chronic conditions.
Early diagnosis of cancer is a key strategy for cancer control 1 and for improving cancer outcomes. However, the majority of patients with cancer have pre-existing chronic conditions at the time of diagnosis, and how to achieve an early diagnosis of cancer among this large and growing group of patients remains unclear. Approximately three out of four patients with cancer have at least one pre-existing chronic disease 2, 3 . The relationship between cancer and other chronic conditions is multidimensional 4, 5 and many nonmalignant conditions share common risk factors with cancer. For example, chronic obstructive pulmonary disease (COPD) and lung cancer are both associated with tobacco smoking; similarly, high alcohol intake and obesity increase the risk of both cancer and non-neoplastic chronic conditions, such as cardiovascular diseases. Chronic conditions can also influence the risk of developing cancer and affect cancer prognosis through biological mechanisms. For example, type 2 diabetes mellitus (subsequently referred to as diabetes) increases the risk of developing colorectal, breast, endometrial, pancreatic and other cancers through complex biological pathways related to insulin-like growth factors, insulin resistance, compensatory increases in insulin levels and prolonged hyperglycaemia [6] [7] [8] . Similarly, some chronic infections (such as hepatitis C) and conditions characterized by dysregulation of the immune system can also increase the risk of developing cancer through biological mechanisms 4 . Additionally, certain treatments for chronic diseases can also influence both the incidence and aggressiveness of cancer. For example, nonsteroidal anti-inflammatory drugs in patients with arthritis 9 , aspirin in patients with cardiovascular disease 10 or metformin in patients with diabetes might all reduce the risk of cancer 6, 11 . Finally, chronic conditions can affect the timeliness of cancer diagnosis by influencing the diagnostic process [12] [13] [14] . In this Review we focus on this latter aspect of associations between chronic diseases and cancer.
In particular, we aim to examine the influence of chronic conditions on the diagnostic process and their Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms effects on two prognostically important diagnostic outcomes: stage at diagnosis and emergency presentation status. Motivated by the limitations of current evidence [15] [16] [17] [18] , we also consider whether the effect varies by chronic disease and cancer type. To elucidate mechanisms through which chronic diseases might influence the diagnosis of cancer, we review the evidence of disease-specific effects on various process measures that characterize the diagnostic pathway: participation in cancer screening; patients' help-seeking for cancer symptoms; clinical decision-making regarding the use of investigations; and time from symptom onset to diagnosis. By considering both previously described and newly identified mechanisms arising from quantitative and qualitative studies, we propose a comprehensive framework that could be used to guide the development of targeted interventions designed to expedite cancer diagnosis. This framework is important for improving patient outcomes in light of the increasing number of individuals with pre-existing chronic conditions at the time of diagnosis 1, 19 .
Defining chronic diseases
Considerable variability exists in the terminology and methods used to measure morbidity (Box 1). Studies often rely on coded patient record entries for episodes of care preceding the diagnosis of cancer. Composite comorbidity measures such as the Charlson comorbidity index are used frequently 20, 21 , often without additional details on the specific morbidities.
The Charlson comorbidity index, which was originally developed to predict 1-year mortality in hospitalized patients 20 , assigns scores to different chronic conditions (for example, +1 for a history of myocardial infarction and +3 for moderate to severe liver disease), thus enabling a weighted summary comorbidity score to be provided for each patient. The score assigned to each condition reflects the mortality risk in patients with the condition of interest versus that of patients without that condition 20, 21 . Disease severity and duration and certain diseases, such as psychiatric conditions, that might be important for a timely diagnosis of cancer are not included in the Charlson index or other similar summary measures. Overall, no gold-standard method exists for measuring comorbidities in the context of cancer 5 and little is known about the performance of summary comorbidity measures when evaluating diagnostic timeliness.
At the same time, many studies include information on specific chronic diseases (as opposed to composite measures) ( Fig. 1 ; Supplementary Table 1 ). Specific information is often identified through case note reviews and patient and/or health-care provider reports. Most available evidence on the effects of chronic disease in patients with cancer is from those who have been diagnosed with one of a few common cancers (colorectal, lung, breast), although some published research is available from studies involving symptomatic individuals not yet diagnosed with cancer (Supplementary Table 1 ).
Effects on diagnostic outcomes Cancer stage at diagnosis
Evidence for the effects of chronic diseases on cancer stage at diagnosis is mixed, with some studies indicating an association with advanced-stage cancer [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] , while others show no effect [37] [38] [39] [40] [41] [42] [43] and some show a reduced risk of advanced-stage cancer among individuals with pre-existing chronic conditions 34, [44] [45] [46] . Certain studies, despite suggesting an association with advanced-stage cancer in some patients, also report a reduced risk of advanced-stage cancer 22, 25, 28, [30] [31] [32] 35 in some patients with nonmalignant chronic diseases ( Fig. 1) .
A large-cohort study conducted in New Zealand 22 , involving 14,096 patients who were diagnosed with different cancers and which provided details on 42 chronic diseases, demonstrated that the majority of the examined chronic diseases are associated with an increased risk of advanced-stage cancer at diagnosis. This risk was particularly high among patients with dementia, neurological, pulmonary, cardiovascular or major psychiatric disorders, with odds ratios (ORs) ranging between 1.27 and 6.26. Psychiatric conditions were also associated with more advanced-stage cancer in other studies 25, 26 including for breast cancer (OR 1.27; P < 0.01) 25 or advanced-stage oesophageal cancer (occurring in 37% versus 18% of patients with versus without psychiatric illness; P = 0.009) 26 . Moreover, according to large US-based studies 36, 42 individuals with certain psychiatric conditions and those with dementia are also more likely to be diagnosed with colon cancer of unknown stage (24% of those with dementia and a diagnosis of colon cancer versus 7.4% with a diagnosis of colon cancer only; P < 0.001, adjusted OR 2.12, 95% CI 1.77-2.55) and using noninvasive methods (imaging, laboratorybased tests) without histological confirmation (adjusted OR 2.02, 95% CI 1.63-2.51) 42 . Possible explanations of this effect might include difficulties in medical decisionmaking regarding benefits and risks of performing invasive investigations in patients with dementia, considering their cognitive impairment and compromised functional status. However, the authors of this study did not provide information on the importance of functional status or the severity of dementia.
As reported in a US-based study including 11,312 patients, those with alcohol and tobacco-related chronic conditions have a higher risk of advanced-stage head and neck cancers at diagnosis compared with those without these comorbidities (39% versus 6%; P < 0.05), irrespective of consultation frequency 33 . The risk of advancedstage prostate cancer at diagnosis has also been shown to increase significantly in patients with severe renal disease, in those with a history of substance abuse and in those with vascular conditions 31 . Furthermore, the risk of advanced-stage breast cancer is increased in patients with diabetes and haematological or psychiatric morbidities 25 (ORs between 1.15 and 2.06; all P < 0.05) in two, large-cohort, US-based studies. According to another United States population-based cohort study 35 , patients with end-stage renal disease (ESRD) requiring dialysis have a higher likelihood of nonlocalized prostate cancer at diagnosis compared with those without ESRD (13.7% versus 6.5%; adjusted relative risk (RR) 2.23, 95% CI 1. 35-4.13 , controlling for sociodemographic factors and comorbidity index); by contrast, these patients have a lower risk of advanced-stage colorectal cancer (CRC) at diagnosis (39.0% versus 50.9%; adjusted RR 0.81, 95% CI 0.66-0.98).
A lower risk of advanced-stage prostate cancer at diagnosis was also reported in a large cohort of individuals with hypertension, dyslipidaemia or coronary artery disease in the United States (ORs 0.67-0.84) 31 . Similarly, a lower risk of advanced-stage breast cancer was reported for individuals with benign breast, gastrointestinal, musculoskeletal or cardiovascular conditions in another large US-based study (ORs 0.62-0.87) 25 .
In a small study (including 72 women), investigators reported varying effects depending on the type of specific psychiatric morbidities; major depression increased the risk of advanced-stage breast cancer, while phobia decreased the risk 30 . Information on consultation frequency was not available. Heterogeneous effects have also been reported in patients with diabetes, depending on its severity 27 ; poorly controlled diabetes was associated with advanced-stage CRC (OR 2.1, 95% CI 1-4.4; P = 0.02), although this was not the case for those with well-controlled diabetes. Disease-specific effects might also be modified by patient-related factors (for example, age), health-care factors and tumour characteristics (such as the symptom 'signature' of the specific cancer), but evidence on possible effect modification is scant.
In summary, the available evidence suggests that the presence of chronic diseases is associated with the stage at diagnosis of cancer, but effects vary by condition. Some diseases, such as dementia, neurological, pulmonary, cardiovascular and major psychiatric disorders are associated with an increased risk of advanced-stage at diagnosis across various cancer types. By contrast, hypertension, dyslipidaemia and benign gastrointestinal and musculoskeletal conditions are associated with a lower risk of advanced-stage at diagnosis. Heterogeneous effects on advanced cancer stage were reported for individuals with ESRD, with an increased risk in patients diagnosed with prostate cancer and a reduced risk in those with CRC.
Diagnosis of cancer as an emergency
In various countries, a substantial minority of patients with cancer are diagnosed in the context of an emergency presentation 17 . Efforts to prevent emergency presentations are justified because such diagnoses are associated with worse clinical outcomes and patient experiences [47] [48] [49] . The majority of evidence suggests that patients affected by chronic conditions have a higher risk of diagnosis of cancer as an emergency 34, 48, [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] (Fig. 1 147 . The precise definition of 'diagnostic delay' varies between studies (for example, >3 months or >6 months). The term 'diagnostic interval' is preferable to 'delay', as the latter relies upon the subjective judgement of the investigators, which might have limited reproducibility 14 . • Patient or help-seeking interval: time between a patient first noticing a symptom to the first medical visit for that symptom. This interval can relate to actual experience or intended help-seeking behaviour. This definition is in line with the Aarhus statement 147 . Certain studies only report 'patient delay' with varying definitions (>3 weeks, >3 months or a median time that is longer compared with that of a specific reference group). Evaluating the patient interval rather than assigning an arbitrary definition of 'delay' is preferable in order to avoid subjective judgements 14 Each circle represents a quantitative study providing information on the effects of chronic diseases on diagnostic timeliness in patients with cancer. Different colours correspond to specific comorbidities described in each study , with blue indicating that only summary comorbidity measures were considered. Letters within each circle specify the cancer examined in the study , with V indicating that several ('various') cancers were included. Thus, each circle provides information on the specific chronic disease and cancer type examined by the study. The circle size reflects the quality of the evidence based on the Mixed Methods Appraisal Tool (MMAT) 150 score, with larger circles corresponding to higher quality scores. The three columns (left to right) highlight if the evidence suggests that chronic conditions are associated with a less timely/no association/more timely cancer diagnosis, respectively. The same study appears in multiple cells if it provides evidence on more than one process and/or outcome measure [151] [152] [153] [154] . 62 . Obesity has also been associated with an increased risk of diagnosis of cancer as an emergency 65 .
By contrast, in a study conducted in Sweden, investigators described a possible 'protective' effect of certain conditions, finding a higher prevalence of hypertension among patients with colon cancer diagnosed as a nonemergency compared with those diagnosed as an emergency 64 . Likewise, monitoring patients in primary care for hypertension was also associated with a lower risk of an emergency diagnosis of colon cancer in a longitudinal population-based study conducted in the United Kingdom, after accounting for symptoms, various comorbidities and sociodemographic factors (for example, among women 70-79 years of age, adjusted OR 0.62, 95% CI 0.43-0.92) 62 .
In summary, similar to the effects on cancer stage at diagnosis, certain chronic conditions, including dementia, and certain neurological and cardiovascular conditions are associated with an increased risk of emergency diagnosis. By contrast, hypertension can be associated with a lower risk of cancer diagnosed as an emergency. This observation is supported by previously mentioned studies suggesting a lower risk of a diagnosis of advanced-stage cancer among patients with hypertension. Hypertension is a risk factor associated with various cardiovascular diseases, rather than a chronic disease per se. However, the management of hypertension, which can involve frequent contact with the health-care system, can influence the timeliness of diagnosis.
Effects on the diagnostic process Participation in cancer screening
Participation in breast cancer screening is higher in women with one chronic condition compared with those with none (adjusted OR 1.31, 95% CI 1.17-1.46, controlling for age, level of education, country of birth and other sociodemographic factors) or two or more conditions (adjusted OR 1.2, 95% CI 1.05-1.32), according to a large, population-based cohort study conducted in Canada 67 . However, after accounting for disability, which is often associated with chronic conditions, women with severe disability are less likely to participate in breast screening compared with those with moderate disability (adjusted OR 0.72, 95% CI 0.63-0.82) or no disability (adjusted OR 0.88, 95% CI 0.78-0.99) 67 . In this study, the highest level of participation in screening (75%) was observed among women with one chronic condition and moderate disability, with the lowest level observed among women with two or more conditions and severe disability (61%) 67 . Similarly, the findings of another large-cohort study conducted in Canada using linked data indicate that women with no chronic health conditions and no disability had the highest level of participation in cervical cancer screening (64.5%), while the lowest proportion was observed among women with two or more morbidities and severe disability (39.8%) 68 . Studies conducted in the United States also suggest that increasing Charlson comorbidity scores are associated with a lower probability of participation in breast and cervical screening, possibly because physicians are less likely to recommend screening in patients with worse overall health status and/or because such patients are more likely to refuse screening 69 . Furthermore, according to a large, population-based cohort study conducted in the United States, participation levels in CRC screening decrease with increasing levels of comorbidity (88% of study participants aged 65-69 years underwent screening if their Charlson score was 0 versus 82% if their score was >4; P < 0.001) 70 .
Considering the effects of specific chronic conditions, two large, population-based surveys conducted in the United States have shown that women ≥40 years of age with diabetes are more likely than those without diabetes to be screened for CRC 71, 72 ; specifically, participation in screening was 63% versus 60% (P < 0.05) among women with versus those without diabetes (adjusted OR 1.14, 95% CI 1.04-1.24, accounting for sociodemographic factors, health insurance status, body mass index and smoking status) 71 . However, the opposite effect was reported in a different United States population-based survey of older women (≥67 years of age; adjusted OR 0.79, 95% CI 0.70-0.88) 73 . These studies included women only, but a prospective survey involving 55-yearold men and women in England has revealed a lower probability of flexible sigmoidoscopy screening for those with diabetes than for those without (adjusted OR 0.48, 95% CI 0.25-0.94) 74 .
Women with diabetes are also less likely to participate in breast cancer screening than those without diabetes according to two large-cohort studies conducted in Canada 75, 76 (60% versus 66%, respectively; OR 0.79, 95% CI 0.78-0.80, accounting for socioeconomic status and overall level of comorbidity) 75 . Similarly, two other studies conducted in Canada found a lower level of participation in breast cancer screening among women with HIV infection than among those without HIV infection (50% versus 63%, respectively) 77 or depression (46% versus 62%, respectively; adjusted OR 0.63, 95% CI 0.40-0.97) 78 , while evidence from Spain indicates that this was also the case in women with obesity (64% versus 69%, respectively) 79 . Two studies from the United States have also demonstrated that obesity is associated with a lower level of participation in breast 80 and cervical 81 screening, after adjustment for sociodemographic factors, health-care access, general health status, other comorbidities and health-seeking behaviour. By contrast, musculoskeletal conditions are associated with a higher probability of participation in breast screening in a study conducted in Spain (75% versus 63% in women with versus those without musculoskeletal conditions, respectively; adjusted OR 1.46, 95% CI 1.22-1.77) 79 .
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In summary, individuals with multiple chronic health conditions are less likely to participate in breast, cervical and CRC screening, especially those who also have severe disability. Regarding specific conditions, HIV infection, depression and obesity are all associated with a lower probability of participation in cancer screening. By contrast, individuals with musculoskele tal conditions are more likely to undergo screening. Heterogeneous effects have been reported for individuals with diabetes.
Help-seeking for symptoms
Pre-existing chronic diseases can influence help-seeking behaviour in the context of both new and changing symptoms. Chronic diseases can have variable effects 63, [82] [83] [84] [85] [86] , with some being associated with shorter 87 and others with longer intervals between the emergence of symptoms and presentation to the healthcare system [88] [89] [90] [91] [92] , while other studies [93] [94] [95] found no such effects ( Fig. 1 ).
Findings of a study involving patients with lung cancer 91 showed that those with COPD took twice as long to consult for symptoms of lung cancer than those without COPD (mean help-seeking interval 166 versus 81 days), while those with a history of renal failure had significantly shorter intervals than those without comorbidities (mean of 53 versus 102 days, respectively). A survey on help-seeking behaviour for various cancer symptoms 90 A small-cohort study conducted in Japan, involving 134 patients with cancer, suggests that individuals with dementia might seek help less frequently for cancer symptoms than those without (8% versus 63%; P < 0.001), as indicated by the finding that cancer has been a 'chance discovery' in 48% of patients with dementia versus 21% of those without dementia 43 .
In summary, evidence of the effects of chronic diseases on help-seeking behaviour is heterogeneous and dependent on the specific chronic condition and form of cancer. Data from some studies showed no association, although other data indicate longer patient intervals in certain scenarios -for example, when chronic conditions and cancer have overlapping symptomatology (COPD and lung cancer) or when patients have 'serious' diseases (such as certain cardiovascular conditions); by contrast, hypertension is associated with help-seeking for potential cancer symptoms.
Diagnostic events postpresentation
Beyond effects on patient help-seeking, chronic diseases can also influence the decision-making of health-care providers (sometimes in combination with patient-specific factors) regarding diagnostic reasoning and referrals for specialist investigations or other diagnostic tests.
Diagnostic processes, referrals and use of investigations.
Several studies providing information on the relationship between chronic conditions and cancer diagnoses 58, 94, [96] [97] [98] only examined the overall effect of any disease (rather than specific diseases) on the diagnostic process ( Fig. 1 ). Having any chronic disease versus none appears to have no significant effect on specialist referrals for gynaecological cancers 94 or on gastroscopy rates 58 .
However, evidence on the effects of specific chronic diseases is provided by several studies 2, 35, 57, 82, 85, 86, 88, 89, 95, [98] [99] [100] [101] . In particular, congestive heart failure or coronary artery disease can lead to missed opportunities to refer patients promptly for endoscopic examinations 100 , despite symptoms of CRC. Psychiatric illness was also associated with prolonged intervals between initial presentation and referral to a specialist or for colonoscopy (with referral occurring after ≥60 days) in a study involving patients with CRC (adjusted OR 4.0, 95% CI 1.1-13.9) 85 . ESRD can have heterogeneous effects according to a cohort study conducted in the United States; this condition increases the likelihood of undergoing colonoscopy or flexible sigmoidoscopy (OR 3.65, 95% CI 1.21-11.03) and decreases the likelihood of undergoing testing for serum prostate-specific antigen levels (OR 0.59, 95% CI 1.21-11.03) 35 .
Diagnostic interval (from first presentation to diag nosis).
Data are available from several studies in which diseasespecific effects on the diagnostic interval were examined 26, 57, 82, 83, 85, 86, 88, 95, 99, 102, 103 ; in others, only the overall effects of any chronic disease were examined 40,41,84,94,97,98,101,104-107 ( Fig. 1 ). Overall, having any pre-existing chronic disease is strongly associated with a longer interval between initial presentation and diagnosis of cancer, according to the findings of two large-cohort studies involving patients with leukaemia or myeloma 105, 106 and one involving patients with lymphoma 97 . For example, patients with chronic lymphocytic leukaemia with a pre-existing chronic health condition (versus those with none) had an increased risk (OR 2.83, 95% CI 2.5-3.3) of a prolonged diagnostic interval (defined as longer than the average duration of 63 days between initial symptomatic presentation and diagnosis) 106 . A longer diagnostic interval has also been reported among patients with cancers of the upper aerodigestive tract with a pre-existing chronic disease versus none (OR 2.84, 95% CI 1.35-5.98) 104 and for those with oral cancers (42% of individuals with a Charlson comorbidity score >3 had a diagnostic interval >1 year, compared with 7% among individuals with a comorbidity score of 1-2 or no comorbidities; P = 0.002) 84 . Similarly, among patients with laryngeal cancers 104 , 42% of patients with a Charlson comorbidity score >3 had a diagnostic interval >1 year, compared with only 7% of patients with a comorbidity score of 0-2.
A UK-based cohort study involving electronic primary care records from patients with CRC 102 showed that specific chronic diseases are associated with longer intervals before cancer diagnosis. In this analysis, inflammatory bowel disease (IBD) was most strongly associated with an increase in the diagnostic interval (median increase of 26 days (95% CI ; and a geometric mean that was 1.33-fold greater (95% CI 1.18-1.51; P < 0.001) in patients with IBD, after controlling for patients' age and gender); other conditions associated with significantly longer diagnostic intervals were coronary heart disease (median increase 15 days, 95% CI 7-24), anxiety and/or depression (median increase 9 days, 95% CI 3-17) and diverticular disease (median increase 14 days, 95% CI 3-27). Effects of pre-existing chronic diseases were stronger in individuals ≥80 years of age. Similarly, depression and/or anxiety and gastrointestinal conditions were associated with longer diagnostic intervals in a large study involving patients with CRC 95 . Psychiatric illness is also associated with a longer diagnostic interval for patients with oesophageal cancer (median 90 days in those with this comorbidity versus 35 days in those without comorbidities; P < 0.001) 26 .
Performance of investigations.
Evidence for the effects of chronic diseases on performance of investigations is scant. No difference in the rate of false-positive diagnosis has been reported in older women undergoing breast cancer screening when stratified by Charlson comorbidity score 108 . However, a higher risk of CRC after no detection of cancer at a previous colonoscopy has been reported in patients with chronic diseases (OR 1.16, 95% CI 1.1-1.3) 96 . Such occurrences are thought to primarily reflect missed lesions or an incomplete polypectomy at the index colonoscopy 109 . Pre-existing diseases might lead to difficulties with bowel preparation 110 and/or increased technical difficulties for the endoscopist 108, 111 or a reduced level of patient tolerance during the examination, thus interfering with the endoscopic examination and possibly increasing the risk of missed lesions.
In summary, the available evidence on the effects of chronic conditions on the diagnostic process indicates that chronic conditions are associated with a reduced likelihood of prompt referral to a specialist, less use of specialist investigations (such as colonoscopy) and prolonged diagnostic intervals. For some conditions, including cardiovascular and psychiatric conditions, such findings have been reported across several cancer types; for other conditions (such as IBD or diverticular disease) this observation applies only to specific cancers presenting with similar symptomatology (CRC). ESRD, unlike other chronic health conditions, can be associated with a higher likelihood of undergoing colonoscopy and/or flexible sigmoidoscopy.
Mechanisms of influence
Quantitative research has enabled certain associations with diagnostic outcomes to be documented, although thus far data from quantitative studies specifically designed to evaluate the mechanisms by which chronic diseases might influence the diagnosis of cancer are limited (Box 2). Currently, details on possible mechanisms are mostly provided by qualitative research (Supplementary Tables 2-3 ).
Alternative explanations
In situations when symptoms of cancer and of a preexisting chronic condition overlap (for example, in the case of COPD and lung cancer 82, 91 ), patients and/or doctors might attribute cancer symptoms to the pre-existing condition or its treatment, thus prolonging the time before the cancer is diagnosed.
Influencing help-seeking for cancer symptoms. Patients might attribute early cancer symptoms that would often lead to clinical presentation to pre-existing nonmalignant chronic diseases or to their treatments 88, 112 . Reports of this effect most frequently relate to chronic respiratory diseases (COPD and asthma) and gastrointestinal conditions (such as inflammatory bowel disease) that can interfere with help-seeking for lung cancer and CRC symptoms, respectively 63, 82, 86, 88, 91 (Supplementary Table 2 ).
Influencing the diagnostic interval. Patients with chronic diseases can have longer diagnostic intervals and an increased risk of diagnosis of cancer as an emergency owing to missed opportunities 57, 82 when symptoms are attributed by the doctor to a pre-existing disease or its treatments, despite repeated symptomatic presentations 63, 86 . Alternative explanations can also be reinforced by doctor-patient interactions 83, 88 (Supplementary  Table 3 ). A series of interviews with general practitioners (GPs) 101 about the diagnosis of lung cancer indicate that, when GPs do not initiate the diagnostic process after the first consultation, patients have a median delay of >45 days (IQR 28-111 days) with chronic diseases contributing to a longer primary care interval in 23% of patients with cancer, most frequently owing to alternative explanations for relevant symptoms. In a study involving patients with CRC 102 , chronic conditions classified as representing 'alternative explanations' increased the diagnostic interval by an average of 9 days; IBD was associated with the largest increase, with a median of 26 days. Reviews of free text notes made by GPs 86 and significant event audits 57 highlighted missed diagnostic opportunities in patients with a history of diverticulitis or gynaecological conditions, with both GPs and specialists initially attributing the symptoms of CRC or ovarian cancers to these conditions or their related medications.
Competing demands
Influencing help-seeking for cancer symptoms. Some chronic diseases might lead to a prolonged patient interval if they are perceived to be of particular gravity (such as heart disease) and thus divert attention from new symptoms, especially if vague. For example, a survey 90 highlighted how having a cardiac condition decreased the likelihood of prompt help-seeking for changes in bowel habits.
Influencing the diagnostic interval. Doctors might prioritize the treatment of pre-existing diseases or worry about a patient's poor health status owing to chronic diseases, thus leading to longer intervals before investigations involving invasive procedures 89 . For example, patients with congestive heart failure or coronary artery disease might not be referred promptly for an endoscopic investigation of possible CRC symptoms 100 . The findings of another study 102 demonstrated that a single 'competing demand' condition (for example, coronary heart disease) increased the diagnostic interval among www.nature.com/nrclinonc those diagnosed with CRC by 10 days, and four or more conditions increased the diagnostic interval by 32 days in the average patient.
Influencing participation in cancer screening. Competing demands might also influence participation in cancer screening, as suggested by the lower probabi lity of appropriate screening in individuals with diabetes, HIV infection or depression. Health-care providers for patients with multiple morbidities, who therefore have more complex needs, have to deal with competing demands and fragmentation of care that often involves multiple specialist services and this possibly interferes with access to preventive services [75] [76] [77] [78] .
Overall, the competing demands mechanism can explain, at least partly, the higher risk of advanced-stage cancer among patients with more severe and/or more complex chronic conditions, such as severe neurological, pulmonary or cardiovascular conditions and those with multiple morbidities.
Box 2 | Mechanisms and examples of how chronic diseases might influence the diagnosis of cancer

Mechanisms interfering with a timely cancer diagnosis
Pre-existing theories • Alternative explanations: cancer symptoms are attributed by patients and/or doctors to a pre-existing chronic condition or its treatment. This theory is particularly relevant when symptoms of cancer and of the chronic condition overlap 18, 25, 31, 102 , including:Chronic obstructive pulmonary disease (CoPD) and lung cancer 82, 91 -Inflammatory bowel disease/irritable bowel syndrome/diverticular disease and colon or ovarian cancers 86, 102 β-Blocker-or statin-associated gastrointestinal symptoms and colorectal cancer (CRC) 88 • Competing demands: chronic conditions that are complex to manage and/or are perceived to be of particular gravity can distract the patient and/or doctor from appraising and investigating new vague symptoms that might be caused by the development of cancer 148 .
-Cardiac conditions and CRC 90,104 • Pathological hypothesis: some chronic conditions or their treatments are able to interact with the pathogenesis of cancer, thus influencing aggressiveness at the cellular or physiological level 25, 113 . (For related effects in the opposite direction see below.) -Diabetes and CRC 27, 114 Novel theories emerging from this Review • over-reassurance (of patients and/or doctors) following diagnostic tests performed during monitoring of a chronic disease.
-ultrasonography for gynaecological conditions and colon cancer 89 • Worry/anxiety regarding being perceived as a hypochondriac owing to frequent consultations for chronic diseases and/or coexisting mental health conditions. This apprehension might influence patients' reporting of symptoms. Frequent consultations can also influence doctors' interpretation of symptoms in light of anxiety disorders 86 .
-Mental health conditions and CRC 63,85,86 • Fatalism (owing to morbidity-related poor health) leading to a reluctance to undergo investigations or cancer screening.
-Multimorbidity and breast cancer or CRC 69, 89 • Communication problems owing to the presence of specific chronic conditions.
-Dementia, mental health, hearing problems and gastrointestinal cancers 26, 43, 47 Mechanisms facilitating a timely cancer diagnosis Pre-existing theories • Surveillance effects/opportunities: frequent consultations for monitoring or treatment can offer patients opportunities to discuss possible cancer symptoms; alternatively, health-care providers might notice new signs and/or symptoms, or recommend cancer screening 149 .
-Hypertension or musculoskeletal conditions and CRC 62, 79, 90, 92 Novel theories emerging from the current Review • Self-efficacy owing to familiarity with the health-care system. Greater self-efficacy can influence patients and indirectly also influence health-care providers' decisions on diagnostic strategies.
-CoPD and lung cancer 82, 92 • Positive expectations owing to previous experiences with chronic disease management.
-Treatment of CoPD-associated chest infections and lung cancer 82 • Priorities with respect to diagnosing cancer early or facilitating access to health services for patients with specific conditions. -CoPD 'management programmes' and lung cancer 92 • Pathological hypothesis: interactions between chronic conditions and/or their treatments (such as aspirin) and cancer can reduce the risk of progression to metastatic disease (via effects on platelet function and others). Biological interactions can also influence symptoms; for example, end-stage renal disease can be associated with gastrointestinal bleeding (owing to uraemic platelet dysfunction and anticoagulation given during dialysis), thus increasing the likelihood of an early cancer diagnosis 35 .
-Aspirin and CRC 10 ; end-stage renal disease and CRC 35
Pathological and biological mechanisms
The effects of chronic diseases on timely cancer diagnosis and cancer stage at diagnosis might also be influenced by biological mechanisms affecting cancer progression. A 'pathological hypothesis' 31 is supported by data from several studies 6, 25, 113 . For example, chronic conditions such as severe renal diseases might be associated with a compromised immune system and metastatic prostate cancer 31 . Moreover, research on diabetes suggests that insulin can have both direct and indirect effects on tumour progression in patients with diabetes and/or obesity 114, 115 . For example, poorly controlled diabetes is associated with an increased risk of advanced-stage CRC 27 , possibly owing to biological effects of chronic hyperinsulinaemia and poor glycaemic control. Pathophysiological interactions between certain chronic diseases (including diabetes and chronic renal disease), ageing and cancer progression have been suggested as possible explanations for the greater risk of advanced-stage forms of different cancers 4, 29, 114, 115 . By contrast, pathological and biological interactions can also reduce the risk of advanced-stage cancer at diagnosis. For example, patients with ESRD requiring dialysis will likely have uraemia-related platelet dysfunction and receive regular anticoagulant treatment, thus increasing the risk of gastrointestinal bleeding. This interaction might explain the higher likelihood of undergoing colonoscopy, leading to earlier detection of CRC in patients with this specific comorbidity 35 .
Novel mechanisms
Some additional mechanisms of influence have emerged during the preparation of this Review (Box 2 and Supplementary Tables 2-3) , which integrate previously hypothesized theories. The following mechanisms are associated with longer patient and diagnostic intervals.
Patient worries about appearing to be a hypochondriac and repeated consultations.
Patients might not seek help for possible cancer symptoms owing to concerns about being seen as a hypochondriac, particularly in the context of mental health conditions 63 . Moreover, dissatisfaction with prior health-care encounters might discourage patients from seeking help promptly for new relevant symptoms -for example, when patients feel that the doctor has previously not been able to help, or they did not feel supported or encouraged to seek help again 89 .
Frequent help-seeking can also influence the doctor's interpretation of symptoms in light of pre-existing anxiety disorders. According to a qualitative analysis of GP free text notes in electronic health records involving patients with CRC 86 , patients consulting frequently for a variety of complaints were less likely to be referred for investigations, possibly because health-care providers sometimes perceive frequent help-seekers as being overly vigilant about small changes in bodily function.
Multiple visits can sometimes be caused by more complex diagnostic processes 99 ; investigations can lead to the diagnosis of previously undetected morbidities that distract health-care providers from diagnosing the underlying cancer, which is then eventually diagnosed after subsequent consultations. In some patients, mental health issues can also influence participation in CRC screening when anxiety disorders interfere with enema administration 116 .
Over-reassurance following investigations performed for a chronic disease.
Over-reassurance can influence both patients and doctors following diagnostic investigations performed in the context of chronic disease management; moreover, a reluctance to refer patients again after a negative test result (which might nonetheless not be sufficiently specific or appropriately targeted to possible cancer) can lead to longer time intervals before the diagnosis of cancer 82, 98 . An analysis of a series of GP interviews also shows that pre-existing conditions can contribute to the misinterpretation of test results or to symptoms being attributed to chronic diseases when cancer is not detected using chest radiography 101 .
Fatalism. Individuals with poor general health status owing to multiple morbidities can be reluctant to undergo invasive diagnostic investigations for possible cancer 89, 92 . Similar mechanisms might also contribute to the lower likelihood of participation in cancer screening of those with poor general health and disabilities associated with multiple morbidities 69 . Mental health conditions are also associated with a lower likelihood of participation in cancer screening, which might be explained in part by a lack of motivation or feeling overwhelmed 116 . For example, severe anxiety and/or depression could impede participation in CRC screening because individuals feel reluctant or unable to administer an enema or because they might feel unable to cope with the consequences of a diagnosis of cancer 116 .
Communication difficulties.
Certain chronic diseases (such as dementia, mental health conditions and hearing problems) can lead to communication difficulties between patients and health-care providers, resulting in longer patient and/or diagnostic intervals 26 . In addition, patients with dementia and/or other mental health conditions can also have difficulties relating to problemsolving behaviour and decision-making, both of which might interfere with a timely cancer diagnosis 42, 43 .
Mechanisms facilitating timely diagnosis Opportunities and surveillance effect
Influencing help-seeking for cancer symptoms. In contrast to the previously discussed mechanisms leading to more advanced-stage cancer at initial diagnosis, some chronic health conditions can be associated with a 'surveillance effect' , which creates opportunities for earlier diagnosis. This effect can occur when a condition requiring regular monitoring enables the reporting of cancer-related symptoms during health-care encounters that are intended to monitor the chronic condition. For example, hypertension and chronic urological conditions can lead to more prompt help-seeking for possible cancer symptoms, such as rectal bleeding or cough 90 . Sometimes patients feel that help-seeking for vague symptoms is only appropriate if the consultation is 'justified' by a coexisting morbidity 117 , consistent with evidence from the United Kingdom that 'not wanting to www.nature.com/nrclinonc waste the GP's time' can be a barrier to help-seeking 118 . No evidence exists for the specific effects of comorbidity by type of health-care system funding.
Influencing the diagnostic interval.
A chronic disease can also offer health-care providers with opportunities to evaluate the possibility of cancer. This opportunity can apply to situations when signs and/or symptoms suggestive of cancer are not mentioned by patients, but are nonetheless noticed by health-care providers when patients are seen for the management of a chronic disease 99 . For example, an analysis of the medical records of patients diagnosed with lung cancer has shown that regular visits for rheumatological conditions can reveal changes in routine blood tests, triggering further investigations (such as chest radiography, resulting in the diagnosis of lung cancer). In some cases, the cancer is detected incidentally when undergoing investigations for another condition. This association has been reported in several patients with COPD and/or heart conditions who are diagnosed with lung cancer opportunistically when undergoing investigations for their pre-existing conditions and without having noticed any concerning change in their symptoms 82 .
Influencing participation in cancer screening. Chronic conditions can also offer opportunities for accessing screening, which might explain the increased likelihood of participation in cancer screening programmes among individuals with musculoskeletal conditions 79 . The exact reasons for this effect are not known, although regular health-care encounters for monitoring or managing chronic conditions can provide opportunities for doctors and patients to discuss the benefits of early diagno sis of cancer and the possibility of undergoing cancer screening.
Overall, regular surveillance of nonmalignant conditions can influence both patients and health-care providers and can contribute to the protective effects of some conditions, such as hypertension, dyslipidaemia or musculoskeletal conditions, which are associated with a lower risk of advanced-stage cancer at diagnosis.
Novel mechanisms
The following additional mechanisms of influence, which seem to be associated with a shorter patient interval (defined as the time between a patient first noticing a symptom to the first medical visit for that symptom) and diagnostic interval (defined as time from first symptomatic presentation in primary care to the diagnosis of cancer) have emerged from this Review (Box 2 and Supplementary Tables 2-3 ).
Self-efficacy and positive expectations.
Familiarity with the health-care provider, owing to regular contact for treatment and/or monitoring of chronic disease, might affect patients' self-efficacy and facilitate help-seeking and communication regarding other health concerns 92 . Moreover, patients with chronic diseases can acquire substantial experience, enabling them to identify subtle changes in their symptoms compared with those of their underlying disease, which can trigger help-seeking 82 .
Patients with chronic diseases can also have pre vious positive experiences of contact with health-care services, thus motivating them to seek help promptly when they anticipate that a prescription can alleviate symptoms 82 .
Priorities and specialist services for patients with chronic diseases.
Specialized care pathways for patients with chronic diseases or nurse-led 'disease management programmes' for certain chronic diseases (such as diabetes or COPD) might facilitate help-seeking for other health concerns, as these services can reduce waiting times and can optimize access to health-care services 92 . Moreover, guidelines and criteria for accessing diagnostic services targeting patients with specific conditions might have a positive influence on cancer diagnosis, by facilitating prompt access to health-care professionals and/or testing among specific higher-risk subgroups 88, 92 .
Improving cancer diagnosis A comprehensive framework
By integrating the available evidence, we developed a comprehensive framework of the likely mechanisms through which chronic diseases can either interfere with or facilitate a timely cancer diagnosis. Such mechanisms include influencing participation in cancer screening, affecting help-seeking behaviours in those with possible cancer symptoms, and the use of diagnostic investigations (Fig. 2) .
Novel mechanisms of influence have emerged (Box 2) into which several previously hypothesized theories including the 'alternative explanations' , 'competing demands' , 'surveillance effect' 18, 25, 31, 102 and 'pathological' hypothesis can also be integrated 25, 113 . Novel mechanisms associated with longer patient and diagnostic intervals include false reassurance and/or over-reassurance (among doctors and patients) following investigations performed for a chronic disease, patient worries about appearing to be a hypochondriac, and fatalism owing to poor health status associated with multiple morbidities leading to a reluctance to undergo invasive diagnostic investigations. The overall health status and prognosis of patients in relation to their chronic diseases can also influence the decision-making of health-care providers and their recommendations to their patients regarding screening as well as diagnostic investigations. By contrast, self-efficacy and positive expectations (related to their chronic conditions), as well as health services and guidelines targeting patients with specific conditions, might all have a positive effect on cancer diagnosis by facilitating prompt access to health-care for patients with higher-risk characteristics.
Notably, associations described in this Review often represent 'average' effects in populations of patients. At the individual level, additional factors (related to the patient or tumour) can come into play. In particular, age, socioeconomic factors (associated with multiple morbidities) 119 and social support might all modify the effects of chronic diseases on diagnostic processes and outcomes. Moreover, multiple mechanisms could apply simultaneously in individual patients.
Some chronic conditions, including dementia, neuro logical, pulmonary, cardiac and psychiatric disorders, are associated with a particularly high risk of cancer diagnosis at an advanced stage across a range of cancer types. By contrast, hypertension, hypercholesterolaemia and some benign musculoskeletal and gastrointestinal diseases might be associated with earlier diagnosis.
Psychiatric illness and dementia are both associated with a late diagnosis of breast, prostate and gastrointestinal cancers. Psychiatric illnesses might provide alternative explanations for cancer symptoms, which could be misinterpreted (by both patients and doctors) as reflecting the effects of underlying psychiatric conditions or medications 26 . Communication difficulties and worries about appearing hypochondriacal might also interfere with the reporting of cancer symptoms in patients with mental health problems 63, 89 . Dementia and other mental disorders can also be associated with cogni tive impairment and difficulties in problem-solving and decision-making, which might interfere with participation in cancer screening, adherence to medical recommendations and diagnostic investigations 36, 42, 43 . For example, cognitive impairment and emotional issues might complicate the informed consent process, therefore discouraging health-care providers from recommending invasive diagnostic investigations 36 ; patients could also not undergo such investigations owing to difficulties in adhering to speci fic recommendations (such as bowel preparation for colonoscopy) 116 . The relationship between dementia and cancer diagnosis is particularly complicated as several studies suggest that a direct biological effect might also affect the diagnosis of cancer, with patients with Alzheimer disease being less likely to develop cancer, as well as being less likely to be diagnosed with cancer through screening 120 . Mental health conditions are common among the general population 26, 121, 122 ; therefore, interventions designed to support the diagnostic process in these patients are needed. Patients with mental health conditions tend to consult frequently but might have difficulties when appraising their symptoms, communicating their health-care needs and navigating the health-care system. Thus, interventions designed to support treating physicians in assessing symptoms and those that support access to health-care services could both be particularly justified.
Aggregate comorbidity measures
Commonly used summary measures, such as the Charlson comorbidity index, were originally developed to predict mortality and can provide useful information on the overall burden of comorbidity experienced by individual patients; however, their suitability for evaluating the effects of chronic diseases on diagnostic timeliness should be carefully considered. All chronic diseases included in the Charlson index are associated with an increased risk of mortality (albeit with dif ferent weights). By contrast, not all chronic conditions increase the risk of advanced-stage cancer. Thus, the same weighted sum used on the basis of associations with mortality could lead to uninformative results in studies designed to assess effects on diagnostic timeliness, given that some conditions might increase and others might decrease the risk of advanced-stage cancer at diagnosis.
The use of summary measures might offer some advantages in terms of statistical analysis, although rather than weighting each condition based on the effects on mortality, different weights would be necessary in order to adapt the index for accurate evaluations of diagnostic timeliness. Weighting might also be dependent on the cancer type.
The severity and duration of the chronic condition and any related treatments are generally not considered in commonly used comorbidity indices, although these factors can influence diagnostic processes and outcomes. Furthermore, certain diseases, such as psychiatric conditions, that might be particularly relevant in the context of timely cancer diagnosis are also not included. Overall, existing summary indices, while being a useful measure of the overall burden of comorbidities, have important limitations and require adaptation and validation before they can be used to evaluate the effects of chronic diseases on the timing of cancer diagnosis. Considering each chronic condition individually might have important merits and could provide useful insights that enable the development of better-targeted health-care interventions.
Limitations of the current evidence
Definitions of chronic disease and the data collection methods used vary substantially across studies and this might have contributed to the variability of findings. The effects of chronic diseases might be influenced by both their severity and their duration, but such information is rarely reported. Data from several studies suggest that competing demands might affect older patients in particular, although evidence of effect modification by sociodemographic characteristics is scant. Many published studies are based on data obtained from retrospective reports by cancer patients and, therefore, recall bias might have influenced the findings 123 . More than half of the studies described in this Review were not specifically designed to investigate the effects of chronic diseases, and relevant information often emerged only after an in-depth examination of full-text publications. Publication bias might have limited the number of studies showing no effect. Most researchers report prevalence odds ratios, which might provide a biased estimate of the prevalence rate ratio if the rare disease assumption is not met (for example, when the outcome of interest is fairly common). Absolute estimates and their difference are particularly useful from a clinical point of view, but investigators examining the effects of chronic conditions on diagnostic timeliness do not consistently report them.
Implications for policy and practice
The evidence described in this Review and the proposed theoretical framework can inform the development of targeted strategies aimed at improving early cancer diagnosis among people with pre-existing chronic health conditions (Box 3).
According to the Social Cognitive Theory 124 a person's decision to seek help can be influenced by various factors, including their perceived ability to discuss a symptom and receive help ('self-efficacy'), sociocultural and structural barriers, opportunities and outcome expectations. Self-efficacy is often affected by the individual's previous experiences and can influence both patient help-seeking and the doctor's decision-making. In this context, chronic diseases present both opportunities to discuss cancer symptoms 117 , but also barriers if the patient and/or their doctor perceives the pre-existing condition as being more important 18, 91 . Developing guidelines that take the possibility of multiple morbidities into account and improving access to appropriate diagnostic services can both have positive effects on the timing of a cancer diagnosis.
Conceptual models of diagnostic safety 13, 17, 125, 126 can help in identifying specific areas for improvement; they highlight how both systems and cognitive factors can contribute to prolonging the time before cancer diagnosis, with several missed opportunities potentially occurring during the different phases of the diagnostic process (initial assessment, diagnostic test performance and interpretation, follow-up and coordination) 13 . The findings of this Review are in line with these conceptual models and highlight how various steps along the diagnostic pathway can be influenced by the presence of chronic diseases, calling for multifaceted interventions.
When patients present with multiple chronic conditions, prioritizing the amount of time dedicated to the management of serious pre-existing conditions versus investigations of new and possibly vague symptoms, parti cularly in the context of limited consultation time, is often necessary. Allowing sufficient time during primary care encounters remains paramount. Information technology 127 and electronic health records could be used by primary care providers to identify patients with the most complex needs, thus enabling the provision of care to be optimized -for example, by involving specialist nurses before and/or after a visit dedicated to patients with multiple morbidities. Similar approaches were suggested in a project for the management of patients with multiple morbidities 128 ; the intervention did not improve patients' quality of life compared with usual care, although effects on the timeliness of cancer diagnosis were not examined. Patients with multiple morbidities and an increased risk of cancer could benefit from information technology-enabled monitoring systems. Scope also exists for enhancing the surveillance effect, by explicitly incorporating a cancer symptom enquiry step into the routine surveillance of patients with chronic diseases.
Multidisciplinary diagnostic centres (introduced in the past 5 years in Denmark and England [129] [130] [131] [132] ) for patients with clinically serious but nonspecific symptoms could also be useful in the diagnosis of patients with preexisting chronic diseases that lead to diagno stic complexities. Such centres have not been speci fically developed for patients with complicating pre-existing conditions, although ongoing evaluations of their effectiveness in achieving a timely diagnosis of cancer might generate relevant evidence in the near future 132, 133 . Greater integration of primary and secon dary care, as well as the wider use of disease management programmes coordinated by specialist nurses (for example, for patients with diabetes or those with mental health problems), could enable easier access to health-care providers.
Greater efforts should be dedicated to raising the awareness of both patients and health-care providers regarding the benefits of cancer screening in patients with multiple morbidities. At the same time, ensuring that screening recommendations take the severity of chronic conditions and the presence of life-limiting conditions into account by evaluating potential benefits and risks remains important 134 . Information materials specifically designed for groups of patients at higher risk that address possible difficulties or concerns might also be useful. Integration of the management of chronic conditions and cancer screening protocols would also seem justified. Primary care-based preventive programmes, based on the age and risk profiles of patients, might be both more acceptable and more cost-effective for patients 135, 136 .
Care coordination, including follow-up monitoring after investigations, is crucial for patients with multiple morbidities, considering the risks of false reassurance after investigations for a chronic disease that might lead to a later diagnosis of cancer. By sharing diagnostic plans with patients and clearly communicating in the event of uncertainty, patients might feel more empowered to raise concerns. Moreover, providing patients with easy and timely access to their medical records and inviting them to proactively follow-up test results rather than waiting to hear back from the doctor might contribute to the prevention of diagnostic delays 99, 137 .
Research priorities
Further research is warranted on the effects of chronic diseases on clinicians' decision-making regarding diagnostic strategies and the use of diagnostic investigations. The limited information available currently is only indirectly provided by a few interview-based studies and significant event audits. Studies examining cognitive processes, including vignette studies, might provide particularly useful insights in the future [138] [139] [140] [141] .
Limited evidence currently exists on the relationship between specific symptom-morbidity pairs 57, 63, 82, 99 (for example, on the relationship between breathlessness in patients with chronic lung or cardiac morbidities leading to longer diagnostic intervals in patients with lung cancer). Large-cohort studies based on data from linked
Box 3 | Helping to develop strategies for improving timely cancer diagnosis
The proposed framework can be used by health-care providers, policy makers and researchers as a method of identifying targets and possible actions for improving the timely diagnosis of cancer among patients with chronic conditions and to identify relevant processes that lead to more advanced-stage cancer at initial diagnosis. Disentangling the various mechanisms of this effect will enable the development of future interventions. For example, individuals with mental health conditions are less likely to participate in cancer screening and can delay help-seeking for possible cancer symptoms. Such individuals are also less likely to be promptly referred if they develop cancer symptoms. These findings suggest that interventions are needed both before the emergence of symptoms and during the early stages of symptomatic cancer.
Moreover, identifying the specific mechanisms of these effects could enable possible targets of interventions to be suggested. For example, individuals with mental health conditions might be concerned about being perceived as a hypochondriac and be more prone to fatalism owing to poor health status (as a result of multiple morbidities), with an increased risk of delays in help-seeking for symptoms. Such patients might also have higher levels of anxiety about investigations and how best to navigate the health-care system, which could interfere with screening and diagnostic testing. Such information could inform the development of the most appropriate support pathways for these vulnerable patients.
The primary care interval can be influenced by mechanisms similar to those affecting the patient interval. Doctors might dismiss possible cancer symptoms in certain patients, for example by interpreting them in light of anxiety disorders in those with mental health conditions who consult frequently (the 'hypochondriac' effect); poor health status might also affect doctors' propensity to refer certain patients for invasive investigations. Clinical decision-support tools and health-care models promoting greater integration of care may be useful.
This framework also highlights areas and mechanisms in which chronic diseases might offer opportunities for earlier diagnosis. For example, the surveillance effect, whereby frequent encounters with health-care providers can offer opportunities to diagnose cancer earlier, could be used in the routine care of patients with mental health conditions. Novel technologies enabling less invasive and simpler testing could be particularly useful for patients whose clinical condition makes it difficult to tolerate invasive tests. Finally, this framework can be used by researchers to identify areas where evidence is currently lacking and further studies are needed. www.nature.com/nrclinonc electronic health records and trials evaluating different diagnostic strategies for patients with specific morbiditysymptom pairs could help in identifying the optimal approaches for earlier diagnosis of cancer in subgroups of patients with certain common chronic diseases. Studies involving the analysis of data from electronic health records could also evaluate the effects of treatments of chronic conditions on the timely diagnosis of cancer at the population level, thus expanding on the currently limited available evidence 10, 86 .
Qualitative studies, including data from both patients and health-care providers, could offer a deeper understanding of the psychological factors that influence helpseeking and diagnostic decision-making in complex clinical situations. Multidisciplinary research, involving cognitive psychologists, could also provide insights into the role of cognitive mechanisms or situational awareness in influencing decision-making processes in such circumstances.
The tolerance of uncertainty by both patients and doctors can also influence diagnostic decisionmaking 141 ; this consideration is especially relevant for patients with multiple morbidities and poor overall health status, and when chronic diseases (for example, cardiac conditions) increase the risks associated with invasive diagnostic investigations. Considerations of the overall prognosis and life expectancy 142, 143 in relation to pre-existing chronic conditions (which might include a history of cancer) may influence diagnostic decisions. Patient preferences when considering the trade-offs between risks and benefits that might emerge from investigations become particularly important in such situations and a better understanding of the role of shared decision-making in the management of patients with multiple morbidities is needed 140, 144 .
Finally, tailored risk-assessment tools that take into account the effects of chronic morbidities and their treatments need to be developed in order to support clinicians in the decision-making process when evaluating the possibility of cancer in patients with multiple morbidities. Currently available tools designed for this purpose are based on generic algorithms 1 , although more sophisticated approaches could take advantage of the opportunities created by emerging technologies such as artificial intelligence.
Conclusions
Chronic diseases have multiple and sometimes contrasting effects on the timeliness of cancer diagnosis. These effects are mediated through various mechanisms and can influence different aspects of the diagnostic process. By evaluating disease-specific effects on participation in cancer screening, help-seeking for potential cancer symptoms and the use of diagnostic investigations, interventions can be identified that lower the risk of diagnosis of cancer at an advanced stage or through emergency presentation in the growing number of individuals with chronic diseases. Interventions could include the development of tailored diagnostic approaches encompassing risk-assessment tools and clinical guidelines targeting specific symptom-morbidity pairs, the allocation of appropriate time and primary care resources for patients with complex needs (including the availability of specialist nurses) and greater integration of diagnostic services between primary and secondary care in order to optimize the management of patients with multiple morbidities and thus expedite cancer diagnosis in individuals with chronic conditions.
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